Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 312

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Structures of the SARS ‐CoV‐2 nucleocapsid and their perspectives for drug design

Open access
Peng, Ya, Du, Ning, Lei, Yuqing, Dorje, Sonam, Qi, Jianxun, Luo, Tingrong, Gao, George F, Song, Hao·2020·The EMBO Journal

Abstract

COVID‐19, caused by SARS‐CoV‐2, has resulted in severe and unprecedented economic and social disruptions in the world. Nucleocapsid (N) protein, which is the major structural component of the virion and is involved in viral replication, assembly and immune regulation, plays key roles in the viral life cycle. Here, we solved the crystal structures of the N‐ and C‐terminal domains (N‐NTD and N‐CTD) of SARS‐CoV‐2 N protein, at 1.8 and 1.5 Å resolution, respectively. Both structures show conserved features from other CoV N proteins. The binding sites targeted by small molecules against HCoV‐OC43 and MERS‐CoV, which inhibit viral infection by blocking the RNA‐binding activity or normal oligomerization of N protein, are relatively conserved in our structure, indicating N protein is a promising drug target. In addition, certain areas of N‐NTD and N‐CTD display distinct charge distribution patterns in SARS‐CoV‐2, which may alter the RNA‐binding modes. The specific antigenic characteristics are critical for developing specific immune‐based rapid diagnostic tests. Our structural information can aid in the discovery and development of antiviral inhibitors against SARS‐CoV‐2 in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2020105938

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 312

Metadata

Authors
Peng, Y., Du, N., Lei, Y., Dorje, S., Qi, J., Luo, T., Gao, G. F., & Song, H.
Venue
The EMBO Journal
Published
2020-09-11
Volume
39
Issue
20
Pages
e105938-e105938
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W3085912969
Cited by
312
References
56
FWCI
5.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structures of the SARS ‐CoV‐2 nucleocapsid and their perspectives for drug design. https://app.cochat.ai/papers/10.15252/embj.2020105938
The paper
Peng, Y., Du, N., Lei, Y., Dorje, S., Qi, J., Luo, T., Gao, G. F., & Song, H. (2020). Structures of the SARS ‐CoV‐2 nucleocapsid and their perspectives for drug design. The EMBO Journal. https://doi.org/10.15252/embj.2020105938

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.